Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905

被引:4
作者
Li, S [1 ]
Zhang, H [1 ]
Hoff, H [1 ]
Sell, C [1 ]
机构
[1] Allegheny Univ, MCP Hahnemann Sch Med, Dept Pathol & Lab Med, Gerontol Res Ctr, Philadelphia, PA 19129 USA
关键词
insulin-like growth factor 1; tyrosine kinase; cell proliferation; transformation;
D O I
10.1006/excr.1998.4167
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have created a deletion mutant of the insulinlike growth factor type 1 receptor (IGF-1 R) which lacks the 36 amino acids (aa) immediately N-terminal to the transmembrane domain (Delta 870-905 IGF-1 R), This region has been reported to have a negative effect on the transforming potential of an avian sarcoma virus gag-IGF-l R fusion protein, We have sought to determine whether this region plays a similar role in the intact IGF-1 R. Analysis of the tyrosine kinase activity of the Delta 870-905 IGF-1 R shows that the mutant receptor is autophosphorylated without IGF-1 stimulation, indicating that the tyrosine kinase domain is constitutively active, In addition, processing of the receptor is decreased, resulting in accumulation of a high molecular weight proreceptor containing both a and beta-subunits. A well-characterized substrate of the IGF-1 R, IRS-1, is constitutively phosphorylated by the Delta 870-905 IGF-1 R and phosphoinositide (PI) 3-kinase activity, which is normally activated by the phosphorylation of IRS-1 following IGF-1 stimulation, is increased even in the absence of IGF-1. A second intracellular signal pathway normally activated by IGF-I, the MAP kinase pathway, showed no increase in activity in the absence of IGF-1. The Delta 870-905 IGF-1 R promoted cell proliferation only in the presence of IGF-1. We conclude that this deletion increases the basal activity of the IGF-1 receptor tyrosine kinase and activates PI 3-kinase, but is unable to stimulate MAP kinase in the absence of ligand, These results confirm those seen in the gag-IGF-l R fusion protein and indicate that aa 870-905 exert a negative effect on the tyrosine kinase domain of the beta-subunit of the IGF-1 R. (C) 1998 Academic Press.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
  • [41] Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
    Hewish, Madeleine
    Chau, Ian
    Cunningham, David
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2009, 4 (01) : 54 - 72
  • [42] c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential
    Wu, Xinqi
    Zhou, Jun
    Rogers, Andrew M.
    Jaenne, Pasi A.
    Benedettini, Elisa
    Loda, Massimo
    Hodi, F. Stephen
    [J]. MELANOMA RESEARCH, 2012, 22 (02) : 123 - 132
  • [43] Expression and purification of functional insulin and insulin-like growth factor 1 holoreceptors from mammalian cells
    Delle Bovi, Richard J.
    Miller, W. Todd
    [J]. ANALYTICAL BIOCHEMISTRY, 2017, 536 : 69 - 77
  • [44] Exploring the Integrated Role of miRNAs and lncRNAs in Regulating the Transcriptional Response to Amino Acids and Insulin-like Growth Factor 1 in Gilthead Sea Bream (Sparus aurata) Myoblasts
    Garcia-Perez, Isabel
    Duran, Bruno Oliveira Silva
    Dal-Pai-Silva, Maeli
    de la Serrana, Daniel Garcia
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [45] Effects of epidermal growth factor receptor and insulin-like growth factor 1 receptor inhibition on proliferation and intracellular signaling in cutaneous SCCHN: Potential for dual inhibition as a therapeutic modality
    Clayburgh, Daniel R.
    Gross, Neil D.
    Proby, Charlotte
    Koide, Jade
    Wong, Melissa H.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (01): : 86 - 93
  • [46] The Role of Insulin-Like Growth Factor 1 in the Development of Benign and Malignant Thyroid Nodules
    Basturk, Engin
    Kement, Metin
    Yavuzer, Dilek
    Vural, Selahattin
    Gezen, Cem
    Gozu, Hulya Iliksu
    Karadayi, Ayse
    Oncel, Mustafa
    [J]. BALKAN MEDICAL JOURNAL, 2012, 29 (02) : 133 - 138
  • [47] Engineered insulin-like growth factor-1 for improved smooth muscle regeneration
    Lorentz, Kristen M.
    Yang, Lirong
    Frey, Peter
    Hubbell, Jeffrey A.
    [J]. BIOMATERIALS, 2012, 33 (02) : 494 - 503
  • [48] Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells
    Bouallegue, Ali
    Vardatsikos, George
    Srivastava, Ashok K.
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2010, 88 (05) : 501 - 509
  • [49] Herbal formula menoprogen alters insulin-like growth factor-1 and insulin-like growth factor binding protein-1 levels in the serum and ovaries of an aged female rat model of menopause
    Wei, Min
    Zheng, Sheng Z.
    Lu, Ye
    Liu, Daniel
    Ma, Hong
    Mahady, Gail B.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (10): : 1125 - 1133
  • [50] Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives
    Xue, Mengzhu
    Cao, Xianwen
    Zhong, Ye
    Kuang, Dong
    Liu, Xiaofeng
    Zhao, Zhenjiang
    Li, Honglin
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (20) : 2901 - 2913